Telix Pharmaceuticals Limited (ASX:TLX)
Australia flag Australia · Delayed Price · Currency is AUD
14.60
-0.35 (-2.34%)
Aug 29, 2025, 4:10 PM AEST

Telix Pharmaceuticals Revenue

Telix Pharmaceuticals had revenue of $390.36M USD in the half year ending June 30, 2025, with 165.59% growth. This brings the company's revenue in the last twelve months to $664.23M, up 55.35% year-over-year. In the year 2024, Telix Pharmaceuticals had annual revenue of $484.69M with 41.49% growth.

Revenue (ttm)
$664.23M
Revenue Growth
+55.35%
P/S Ratio
4.88
Revenue / Employee
$2.84M
Employees
234
Market Cap
4.94B AUD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024484.69M142.12M41.49%
Dec 31, 2023342.57M233.76M214.82%
Dec 31, 2022108.81M103.29M1,870.12%
Dec 31, 20215.52M1.50M37.33%
Dec 31, 20204.02M1.57M64.26%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited23.73B
Pro Medicus212.98M
Cochlear2.34B
Sonic Healthcare9.65B
Ramsay Health Care17.85B
Ansell3.06B
Mesoblast26.23M
Neuren Pharmaceuticals218.86M
Revenue Rankings